Because nuclear localization of YB-1, which is frequently detected in cancers treated with chemotherapeutic agents, is important for E1B55K-deleted adenovirus replication, synergy of antitumor activity occurs with combination of oncolytic adenoviruses and chemotherapeutic agents. This evidence concerns the gene YBX1 and cancer.